Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma

Caroline Robert*, Antoni Ribas, Omid Hamid, Adil Daud, Jedd D. Wolchok, Anthony M. Joshua, Wen Jen Hwu, Jeffrey S. Weber, Tara C. Gangadhar, Richard W. Joseph, Roxana Dronca, Amita Patnaik, Hassane Zarour, Richard Kefford, Peter Hersey, Jin Zhang, James Anderson, Scott J. Diede, Scot Ebbinghaus, F. Stephen Hodi

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    395 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science